Abstract
During the past several decades, there has been an explosion in the prevalence of obesity. Since our genes have not changed appreciably during that time, it stands to reason that the present epidemic is caused by our pervasive obesigenic environment, in which excess caloric intake and decreased physical activity conspire with one another. Despite an obesigenic environment, humans have great variability in their susceptibility to obesity, which is determined in large part by genetics. Current evidence suggests that genetic susceptibility to human obesity is the result of multiple genes, each with a modest effect, that interact with each other and with environmental provocations. Elucidation of obesity susceptibility genes through genome-wide and candidate gene approaches provides great promise in ultimately determining the genetic underpinnings of obesity. Further research will translate these new insights on the pathophysiological basis of obesity into new medications and diagnostic tests.
Similar content being viewed by others
Abbreviations
- PPAR-γ:
-
peroxisome proliferator-activated receptor-γ
- P/S:
-
polyunsaturated fat to saturated fat ratio
References
O’Brien, P.E., and Dixon, J.B. (2002) The Extent of the Problem of Obesity, Am. J. Surg. 184, S4-S8.
National Center for Health Statistics, Prevalence of Overweight and Obesity Among Adults, National Center for Health Statistics, Centers for Disease Control and Prevention, Atlanta, available (accessed February 13, 2003).
Adler, A. (2002) Obesity and Target Organ Damage: Diabetes, Int. J. Obes. Relat. Metab. Disord. 26, S11-S14.
Flegal, K.M., Carroll, M.D., Ogden, C.L., and Johnson, C.L. (2002) Prevalence and Trends in Obesity Among U.S. Adults, 1999–2000, JAMA 288, 1723–1727.
Pi-Sunyer, F.X. (2002) The Medical Risks of Obesity, Obes. Surg. 12, S6-S11.
Stunkard, A.J., Sorensen, T.I., Hanis, C., Teasdale, T.W., Chakraborty, R., Schull, W.J., and Schulsinger, F. (1986) An Adoption Study of Human Obesity, N. Engl. J. Med. 314, 193–198.
Allison, D.B., Kaprio, J., Korkeila, M., Koskenvuo, M., Neale, M.C., and Hayakawa, K. (1996) The Heritability of Body Mass Index Among an International Sample of Monozygotic Twins Reared Apart, Int. J. Obes. Relat. Metab. Disord. 20, 501–506.
Coady, S.A., Jaquish, C.E., Fabsitz, R.R., Larson, M.G., Cupples, L.A., and Myers, R.H. (2002) Genetic Variability of Adult Body Mass Index: A Longitudinal Assessment in Framingham Families, Obes. Res. 10, 675–681.
Rice, T., Perusse, L., Bouchard, C., and Rao, D.C. (1999) Familial Aggregation of Body Mass Index and Subcutaneous Fat Measures in the Longitudinal Québec Family Study, Genet. Epidemiol. 16, 316–334.
Comuzzie, A.G., Blangero, J., Mahaney, M.C., Haffner, S.M., Mitchell, B.D., Stern, M.P., and MacCluer, J.W. (1996) Genetic and Environmental Correlations Among Hormone Levels and Measures of Body Fat Accumulation and Topography, J. Clin. Endocrinol. Metab. 81, 597–600.
Neel, J.V. (1962) Diabetes Mellitus; A “Thrifty” Genotype Rendered Detrimental by Progress? Am. J. Hum. Genet. 14, 353–363.
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J.M. (1994) Positional Cloning of the Mouse Obese Gene and Its Human Homologue, Nature 372, 425–432.
Chen, H., Charlat, O., Tartaglia, L.A., Woolf, E.A., Weng, X., Ellis, S.J., Lakey, N.D., Culpepper, J., Moore, K.J., Breitbart, R.E., et al. (1996) Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice, Cell 84, 491–495.
Naggert, J.K., Fricker, L.D., Varlamov, O., Nishima, P.M., Rouille, Y., Steiner, D.F., Carroll, R.J., Paigen, B.J., and Leiter, E.H. (1995) Hyperproinsulinaemia in Obese Fat/Fat Mice Associated with a Carboxypeptidase E Mutation Which Reduces Enzyme Activity, Nat. Genet. 10, 135–142.
Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J., and Cone, R.D. (1997) Role of Melanocortinergic Neurons in Feeding and the Agouti Obesity Syndrome, Nature 385, 165–168.
Kleyn, P.W., Fan, W., Kovats, S.G., Lee, J.J., Pulido, J.C., Wu, Y., Berkemeier, L.R., Misumi, D.J., Holmgren, L., Charlat, O., et al. (1996) Identification and Characterization of the Mouse Obesity Gene Tubby: A Member of a Novel Gene Family, Cell 85, 281–290.
Nagle, D.L., McGrail, S.H., Vitale, J., Woolf, E.A., Dussault, B.J., Jr., DiRocco, L., Holmgren, L., Montagno, J., Bork, P., Huszar, D., et al. (1999) The Mahogany Protein Is a Receptor Involved in Suppression of Obesity, Nature 398, 148–152.
Clement, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.M., et al. (1998) A Mutation in the Human Leptin Receptor Gene Causes Obesity and Pituitary Dysfunction, Nature 392, 398–401.
Montague, C.T., Farooqui, I.S., Whitehead, J.P., Soos, M.A., Rau, H., Wareham, N.J., Sewter, C.P., Digby, J.E., Mohammed, S.N., Hurst, J.A. et al. (1997) Congenital Leptin Deficiency Is Associated with Severe Early-Onset Obesity in Humans, Nature 387, 903–908.
Jackson, R.S., Creemers, J.W., Ohagi, S., Raffin-Sanson, M.L., Sanders, L., Montague, C.T., Hutton, J.C., and O’Rahilly, S. (1997) Obesity and Impaired Prohormone Processing Associated with Mutations in the Human Prohormone Convertase 1 Gene, Nat. Genet. 16, 303–306.
Farooqi, I.S., Yeo, G.S., Keogh, J.M., Aminian, S., Jebb, S.A., Butler, G., Cheetham, T., and O’Rahilly, S. (2000) Dominant and Recessive Inheritane of Morbid Obesity Associated with Melanocortin 4 Receptor Deficiency, J. Clin. Invest. 106, 271–279.
Rankinen, T., Perusse, L., Weisnagel, S.J., Snyder, E.E., Chagnon, Y.C., and Bouchard, C. (2002) The Human Obesity Gene Map: The 2001 Update, Obes. Res. 10, 196–243.
Walston, J., Silver, K., Bogardus, C., Knowler, W.C., Celi, F.S., Austin, S., Manning, B., Strosberg, D., Stern, M.P., Raben, N., et al. (1995) Time of Onset of Non-insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic-Receptor Gene. N. Engl. J. Med. 333, 343–347.
Widen, E., Lehto, M., Kanninen T., Walston, J., Shuldiner, A.R., and Groop, L.C. (1995) Association of a Polymorphism in the β3-Adrenergic-Receptor Gene with Features of the Insulin Resistance Syndrome in Finns, N. Engl. J. Med. 333, 348–351.
Clement, K., Vaisse, C., Manning, B.S.J., Basdevant, A., Guy-Grand, B., Silver, K., Shuldiner, A.R., Froguel, P., and Strosberg, A.D. (1995) Genetic Variation in the β3-Adrenergic-Receptor and Increased Capacity to Gain Weight in Patients with Morbid Obesity, N. Engl. J. Med. 333, 352–354.
Yen, C.J., Beamer, B.A., Negri, C., Silver, K., Brown, K.A., Yarnall, D.P., Burns, D.K., Roth, J., and Shuldiner, A.R. (1997) Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPAR γ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPAR γ2 Missense Mutation, Biochem. Biophys. Res. Commun. 241, 270–274.
Beamer, B.A., Yen, C.J., Andersen, R.E., Muller, D., Elahi, D., Cheskin, L.J., Andres, R., Roth, J., and Shuldiner, A.R. (1998) Association of the Pro12Ala Variant in the Peroxisome Proliferator-Activated Receptor-γ2 Gene with Obesity in Two Caucasian Populations, Diabetes 47, 1806–1808.
Hoffstedt, J., Poirier, O., Thorne, A., Lonnqvist, F., Herrmann, S.M., Cambien, F., and Arner, P. (1999) Polymorphism of the Human β3-Adrenoceptor Gene Forms a Well-Conserved Haplotype That Is Associated with Moderate Obesity and Altered Receptor Function, Diabetes 48, 203–205.
Tchernof, A., Starling, R.D., Turner, A., Shuldiner, A.R., Walston, J.D., Silver, K., and Poehlman, E.T. (2000) Impaired Capacity to Lose Visceral Adipose Tissue During Weight Reduction in Obese Postmenopausal Women with the Trp64Arg β3-Adrenoceptor Gene Variant, Diabetes 49, 1709–1713.
Kim-Motoyama, H., Yasuda, K., Yamaguchi, T., Yamada, N., Katakura, T., Shuldiner, A.R., Akanuma, Y., Ohashi, Y., Yazaki, Y., and Kadowaki, T. (1997) A Mutation of the β3-Adrenergic Receptor Is Associated with Visceral Obesity but Decreased Serum Triglyceride, Diabetologia 40, 469–472.
Sakane, N., Yoshida, T., Umekawa, T., Kondo, M., Sakai, Y., and Takahashi, T. (1997) β3-Adrenergic-Receptor Polymorphism: A Genetic Marker for Visceral Fat Obesity and the Insulin Resistance Syndrome, Diabetologia 40, 200–204.
Shuldiner, A.R., and Sabra, M. (2001) Trp64Arg β3-Adrenoceptor: When Does a Candidate Gene Become a Disease Susceptibility Gene? Obes. Res. 9, 806–809.
Dionne, I.J., Turner, A.N., Tchernof, A., Pollin, T.I., Avrithi, D., Gray, D., Shuldiner, A.R., and Poehlman, E.T. (2001) Identification of an Interactive Effect of β3- and α2b-Adrenoceptor Gene Polymorphisms on Fat Mass in Caucasian Women, Diabetes 50, 91–95.
Hsueh, W.C., Cole, S.A., Shuldiner, A.R., Beamer, B.A., Blangero, J., Hixson, J.E., MacCluer, J.W., and Mitchell, B.D. (2001) Interactions Between Variants in the δ3-Adrenergic Receptor and Peroxisome Proliferator-Activated Receptor-γ2 Genes and Obesity, Diabetes 24, 672–677.
Mentuccia, D., Proietti-Pannunzi, L., Tanner, K., Bacci, V., Pollin, T.I., Poehlman, E.T., Shuldiner, A.R., and Celi, F.S. (2002) Association Between a Novel Variant of the Human Type 2 Deiodinase Gene Thr92Ala and Insulin Resistance: Evidence of Interaction with the Trp64Arg Variant of the δ3-Adrenergic Receptor, Diabetes 51, 880–883.
Deeb, S.S., Fajas, L., Nemoto, M., Pihlajamaki, J., Mykkanen, L., Kuusisto, J., Laakso, M., Fujimoto, W., and Auwerx, J. (1998) Pro12Ala Substitution in PPARγ2 Associated with Decreased Receptor Activity, Lower BMI and Improved Insulin Sensitivity, Nat. Genet. 20, 284–287.
Celi, F.S., and Shuldiner, A.R. (2002) The Role of Peroxisome Proliferator-Activated Receptor Gamma in Diabetes and Obesity, in Current Diabetes Reports (Elbein, S., ed.), pp. 179–185, Current Sciences, Philadelphia.
Stumvoll, M., and Haring, H. (2002) The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism, Diabetes 51, 2341–2347.
Altshuler, D., Hirschhorn, J.N., Klannemark, M., Lindgren, C.M., Vohl, M.C., Nemesh, J., Lane, C.R., Schaffner, S.F., Bolk, S., Brewer, C., et al. (2000) The Common PPARγ Pro12Ala Polymorphism Is Associated with Decreased Risk of Type 2 Diabetes, Nat. Genet. 26, 76–80.
Cole, S.A., Mitchell, B.D., Hsueh, W.C., Pineda, P., Beamer, B.A., Shuldiner, A.R., Comuzzie, A.G., Blangero, J., and Hixson, J.E. (2000) The Pro12Ala Variant of Peroxisome Proliferator-Activated Receptor-γ2 (PPAR-γ2) Is Associated with Measures of Obesity in Mexican Americans, Int. J. Obes. Relat. Metab. Disord. 24, 522–524.
Nicklas, B.J., vanRossum, E.F.C., Berman, D.M., Ryan, A.S., Dennis, K.E., and Shuldiner, A.R. (2001) Genetic Variation in the Peroxisome Proliferator-Activated Receptor-γ2 Gene (Pro12Ala) Affects Metabolic Responses to Weight Loss and Subsequent Weight Gain, Diabetes 50, 2172–2176.
Luan, J., Browne, P.O., Harding, A.H., Halsall, D.J., O’Rahilly, S., Chatterjee, V.K., and Wareham, N.J. (2001) Evidence for Gene-Nutrient Interaction at the PPARγ Locus, Diabetes 50, 686–689.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Shuldiner, A.R., Munir, K.M. Genetics of obesity: More complicated than initially thought. Lipids 38, 97–101 (2003). https://doi.org/10.1007/s11745-003-1037-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-003-1037-5